A team of Australian researchers has used artificial intelligence to design a new type of protein that specifically targets antibiotic-resistant Escherichia coli. The discovery holds strong potential for medical use, though clinical trials to assess its safety and effectiveness are still needed.
Deutsch
English
Español
Français
Italiano
Nederlands
Polski
Português
Русский
Türkçe
Svenska
Chinese
Magyar